Original paper
New cyclodextrin-based nanocarriers for drug delivery and phototherapy using an irinotecan metabolite
Abstract
SN38 is an active metabolite of irinotecan, which was approved for clinical use in metastatic colorectal cancers. However, poor aqueous solubility and inactivation at pH below 6 are the main limitations of its use. In the current study, we separately conjugated α-, β- and γ-cyclodextrins to graphene oxide sheets to produce stable, biocompatible nanocarriers for SN38 delivery. The conjugates were coordinated with Fe3O4 in the form of...
Paper Details
Title
New cyclodextrin-based nanocarriers for drug delivery and phototherapy using an irinotecan metabolite
Published Date
Aug 1, 2018
Journal
Volume
194
Pages
103 - 110
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History